Walter M. Stadler to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications Walter M. Stadler has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.353
-
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer. Cancer Chemother Pharmacol. 2002 Aug; 50(2):160-2.
Score: 0.195
-
First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Cancer Chemother Pharmacol. 2016 Jan; 77(1):155-62.
Score: 0.123
-
New chemotherapy regimens for advanced bladder cancer. Semin Urol Oncol. 1998 Feb; 16(1):23-9.
Score: 0.036